3-((3-cholamidopropyl)dimethylammonium)-1-propanesulfonate has been researched along with taurodehydrocholate in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Coleman, R; Kan, KS; Parslow, RA; Rahman, K | 1 |
1 other study(ies) available for 3-((3-cholamidopropyl)dimethylammonium)-1-propanesulfonate and taurodehydrocholate
| Article | Year |
|---|---|
Retrograde intrabiliary injection of amphipathic materials causes phospholipid secretion into bile. Taurocholate causes phosphatidylcholine secretion, 3-[(3-cholamidopropyl)dimethylammonio]-propane-1-sulphonate (CHAPS) causes mixed phospholipid secretion.
Topics: Animals; Bile; Bile Acids and Salts; Cholic Acids; Liver; Male; Phosphatidylcholines; Phospholipids; Rats; Rats, Inbred Strains; Taurocholic Acid | 1989 |